The Committee for Medicinal Products for Human Use recommends marketing approval for Merck's Keytruda for treating two types ...

The FDA approves MRK's Keytruda for first-line treatment of malignant pleural mesothelioma. This marks Keytruda's first ...

Today we highlight research findings reported at ESMO 2024, the annual meeting of the European Society of Medical Oncology.

“The conclusion from the world’s top scientific experts at the conference was that Keytruda should be standard of care for early-stage triple negative breast cancer. If this could happen in New ...

Recent studies presented at the ESMO meeting affirm the safety of breastfeeding for breast cancer survivors and highlight the ...

So I think that's also helped us this growth. And certainly, our two key drivers have been KEYTRUDA and GARDASIL. And when I look at KEYTRUDA back in 2019, internationally, we only had 12 indications.

The gross proceeds to the Company from the exercise of the Existing Warrants together with the sale of the new warrants is expected to be approximately $6.2 million. The closing of the transaction is ...

(MRK) said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug Keytruda in combination with pemetrexed and platinum chemotherapy as a first-line treatment for ...

Folks with "high-risk" bladder cancers -- tumors that had already invaded nearby muscle -- doubled the time they were ...